ArticleAesthetic surgery journal. Open forum2024
Evaluation of a Combination Approach to Improving Muscle Tone and Decreasing Subcutaneous Tissue Thickness Using a Sequential, Dual-Modality, Energy-Based Device.
Article in Aesthetic surgery journal. Open forum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical Evaluation of a 1060-Nm Laser for Non-Invasive Fat Reduction of the Abdomen and Coulotte/Thighs in Men and Women.Journal of cosmetic dermatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The body shaping market has long been at the forefront of the aesthetic industry. With technological advances, patient demand for body sculpting in terms of reduction in subcutaneous tissue and enhancement of muscle has seen continual growth. Several devices have emerged in the space; however, few achieve both subcutaneous tissue reduction (SQR) and voluntary muscle increase (VMI) as measured by thickness, during the same treatment session. Objectives: This article presents the results of a pilot study on a unique approach to subcutaneous tissue reduction and increasing muscle thickness using a dual-modality, energy-based device. Methods: Twelve compliant patients (8 females and 4 males with an average age of 40 years) were enrolled in this single center, prospective study. All patients were treated with the dual-modality device (850 nm superluminescent diode matrix and electrical muscle stimulation), with external applicators being placed over the lower abdomen. The patients received 5 weekly treatments. Ultrasound measurements, photographs, weight, and waist measurements were taken at baseline, prior to the start of the fifth treatment, and at the 2-week and 2-month follow-up visits. Results: At the 2-month follow-up visit, the average SQR was 34.03% and the VMI measured 22.97% in all patients who completed the study. All patient and physician evaluations rated the results as satisfactory or better. There were no complications. Conclusions: Preliminary data show this dual-modality, electrical muscle stimulation/superluminescent diode matrix system provides both a safe and effective treatment for the reduction of subcutaneous tissue thickness and an increase in muscle definition and thickness. Objective and subjective evaluations demonstrated high levels of efficacy and satisfaction in all patients. Level of Evidence 2:
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.